MediWound Announces Positive Top-Line Results from Its Pivotal Phase 3 Study (DETECT) in NexoBrid® for Eschar Removal of Severe Thermal Burns

Stock Information for MediWound Ltd.

Loading

Please wait while we load your information from QuoteMedia.